Geoffrey Saunders

Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study

Saye Khoo, Richard J. Fitzgerald, Sean Ewings et al. · Journal of Antimicrobial Chemotherapy · 2021 · 111 citations · Full text

Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial

Saye Khoo, Richard J. Fitzgerald, Geoffrey Saunders et al. · The Lancet Infectious Diseases · 2022 · 76 citations · Full text

Vaccination, Covid-19 Pandemic, Vaccine Trial +8

Evaluation of the Harmonic Scalpel for Laparoscopic Bilateral Ovariectomy in Standing Horses

Katja F. Düsterdieck, R. Scott Pleasant, Otto I. Lanz et al. · Veterinary Surgery · 2003 · 53 citations

Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial

I’ah Donovan-Banfield, Rebekah Penrice-Randal, Hannah Goldswain et al. · Nature Communications · 2022 · 42 citations · Full text

The effectiveness of benzimidazole derivatives for the treatment and prevention of histomonosis (blackhead) in turkeys

F.N Hegngi, J. A. Doerr, T.S. Cummings et al. · Veterinary Parasitology · 1999 · 28 citations

Benzimidazole Derivatives, Antiparasitic Agent, Pharmacology +5